Factory 99% Vidarabine Powder CAS 5536-17-4 Chemical Intermediate Antiviral Vidarabine

• Customization: Available
• Powder: Yes
• Customized: Customized
• Model NO.: A568
• Suitable for: Elderly, Children, Adult
• State: Powder
• Purity: >99%
• Name: Vidarabine
• CAS: 5536-17-4
• Appearance: White Powder
• Assay: 99%
• OEM: Available
• Sample: Available
• Suitable: Adult
• MOQ: 10g
• Function: Antiviral
• Transport Package: Foil Bag
• Specification: 99
• Trademark: /
• Origin: China
• Production Capacity: 10000 Kgs Per Month

Product Description

Product Name	Vidarabine
Appearance	White Powder
CAS NO.	5536-17-4
MF	C10H13N5O4
Storage	Keep in a cool, dry, dark location

 

Vidarabine, chemically designated as 9-β-D-Arabinofuranosyladenine, is a nucleoside antiviral agent derived from adenine. It is specifically designed to interfere with the replication process of certain viruses. By mimicking the structure of adenine, vidarabine can be incorporated into the viral DNA, causing the termination of the DNA chain and ultimately preventing the virus from multiplying effectively.

 

1. Ophthalmic Use: Employed topically for the treatment of herpes simplex keratitis, an infection affecting the cornea caused by the herpes simplex virus.
2. Systemic Therapy: Administered systemically for severe cases of chickenpox and shingles, particularly in immunocompromised individuals, caused by the varicella-zoster virus.
3. Experimental Applications: Explored in the treatment of other viral infections, including hepatitis and certain types of encephalitis, although its use in these conditions is less established.

1. Inhibition of Viral Replication: Vidarabine disrupts viral DNA synthesis by incorporating into the viral DNA chain, causing premature termination and preventing effective viral replication.
2. Selective Antiviral Activity: It exhibits selective toxicity towards specific viruses, such as herpesviruses, making it a targeted therapy for these infections.
3. Potential Immunomodulatory Effects: Although less well-understood, vidarabine may also regulate the immune response to viral infections, contributing to its therapeutic benefits.